相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing
Jorge Arca-Suarez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2022)
Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae from a Major Public Health Hospital in Singapore
Jocelyn Qi-Min Teo et al.
MICROBIOLOGY SPECTRUM (2022)
Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
Jocelyn Qi-Min Teo et al.
MSPHERE (2021)
Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria
Glen T. Hansen
INFECTIOUS DISEASES AND THERAPY (2021)
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals
Mariana Castanheira et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
Jocelyn Qi-Min Teo et al.
EMERGING MICROBES & INFECTIONS (2021)
Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam
Ruslan Tsivkovski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016
Shu-Chen Kuo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations The Price of Progress
Krisztina M. Papp-Wallace et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2020)
A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
Nicholas Van Hise et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
Irene Galani et al.
BMC INFECTIOUS DISEASES (2019)
Eravacycline: The Tetracyclines Strike Back
Maria Heaney et al.
ANNALS OF PHARMACOTHERAPY (2019)
High Rate of Association of 16S rRNA Methylases and Carbapenemases in Enterobacteriaceae Recovered from Hospitalized Children in Angola
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Nonlinear Protein Binding: Not What You Think
Amelia N. Deitchman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding
Ravi Shankar Prasad Singh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae
Olga Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore
Kalisvar Marimuthu et al.
CLINICAL INFECTIOUS DISEASES (2017)
Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot
Jocelyn Qi Min Teo et al.
MICROORGANISMS (2016)